Placebo--efficacy and adverse effects in controlled clinical trials

Area of Science:

• Pharmacology
• Clinical Trials
• Evidence-Based Medicine

Background:

• The therapeutic efficacy of placebos is well-established.
• Adverse drug reactions (ADRs) from placebo treatment are less recognized but significant.
• Systematic study of placebo-induced ADRs from controlled trials is needed.

Purpose of the Study:

• To systematically investigate placebo drug reactions from controlled trials.
• To analyze the efficacy and safety of placebos across diverse therapeutic areas.
• To compare placebo effects and ADRs with active treatments.

Main Methods:

• Pooled patient and drug data from randomized, placebo-controlled, multicentre studies.
• Investigation across five indication groups: cardiology, neurology/psychiatry, metabolism, and gastroenterology.
• Analysis of efficacy and adverse event profiles for both placebo and active treatments.

Main Results:

• Placebo efficacy varied significantly across and within indication groups.
• In some conditions, placebo was as effective as active treatment (e.g., mild neurological deficits).
• Placebo treatment frequently caused ADRs, with profiles often similar to active treatments, and sometimes even more frequent (e.g., dry mouth).

Conclusions:

• Placebo treatment is an active intervention, not 'non-treatment', demonstrating frequent efficacy.
• Placebo effects and ADRs are disease- and active treatment-specific, necessitating direct comparison for accurate assessment.
• Understanding placebo mechanisms and effects is vital for evidence-based medicine and avoiding harmful pseudoplacebo prescriptions.